Q: How do you rate SNY and IMGN ? Are they buys ? Thank you for your valuable advice.
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Good Morning any thoughts about the news this morning in regards to the CRA tax re-assement? Looks like CRA and QRA are challenging the sale of the voucher back in 2014 and concluded that GUD owes $42MM. Gud plans on appealing this, any thoughts on this issue?
Thanks
Thanks
- HashiCorp Inc. (HCP)
- Johnson & Johnson (JNJ)
- Medical Facilities Corporation (DR)
- Novartis AG (NVS)
- AstraZeneca PLC (AZN)
Q: Healthcare is approximately 10% of our portfolio. Medical Facilities is the largest investment which we have held for a long time. JNJ and HCP we have added more recently. NVS and AZN we inherited. We want to simplify our portfolio and plan to sell NVS and AZN and add to JNJ. Wonder what your opinion is of DR and HCP specifically and also AZN which I didn't see mentioned in your question section.
Thank you, Marie
Thank you, Marie
Q: The GUD investing thesis is largely based on management including past success with Paladin. Paladin was certainly a well run company and created lots of value for shareholders so credit to management is not misplaced. But, do you think that the ultimate success with Paladin was more a function of incredibly lucky timing to have been taken out during a really crazy pharma cycle? In other words, how much credit goes to management and how much goes to a once in a generation crazy pharma cycle?
Q: Hi Ryan any shorts on this it seems under a lot of down ward pressure
Kind Regards
Stan
Kind Regards
Stan
Q: Could I have your views on the latest second quarter financial results for this company? Many tnx.
Q: I think looking at chart at $ 16.00 SIS is a buy. When do they report next eps. I see ACORN ads on TV . Same product Chair Lift. I believe Acorn is a UK Company. Your thoughts pleas. RAK
Q: Is COV's wound healing technology exclusive to them by patent? Is this their competitive edge?
Carl
Carl
Q: What can you tell me about Revive Therapeutics. I know it's risky and you likely won't recommend it, but any information would be helpful. The stock has jumped on news of receiving orphan drug status for one of their programs. Is this overly significant? I know it creates excitement, but ultimately how does it add to the actual value of the stock?
Q: could you please give me the ETF's if any in the nursing home field Can. and/or US
aso any top rated health care ETF thanks Paul
aso any top rated health care ETF thanks Paul
Q: Hi. I hold a position of INVESCO S&P S/C HLTH CARE ETF in my portfolio. It's a diversified (75 stocks) US small cap healthcare ETF.
I would like your opinion please. Thank you.
I would like your opinion please. Thank you.
Q: I’m trying to reduce the number of stocks I hold and am wondering which you would prefer in health care for growth - COV or BEAT?
Q: Hi team, I would like to add some US health care (which I know you don't cover) to my non-registered account for a long term hold and was wondering which one you like better between SYK and ISRG. I am ok with some risk.
Thanks
Thanks
Q: Any info to account for the move today. Up 18%.
Thanks
John
Thanks
John
- AbbVie Inc. (ABBV)
- Johnson & Johnson (JNJ)
- Knight Therapeutics Inc. (GUD)
- Savaria Corporation (SIS)
- iShares U.S. Medical Devices ETF (IHI)
Q: Hello, I am looking to add IHI to the healthcare allocation of my portfolio (10%) but would like to sell one existing holding first. Current healthcare related holdings are JNJ, ABBV, GUD and SIS (although I have SIS filed under Industrials). My question: which of JNJ and ABBV would you advise selling? Thank-you.
Q: I know you don't have much info. on use co. but was wondering if anyone had anything on this co. Thank for valuable information and guidance over the years.I have been a member from the start and without your guidance I would have quit the stock market.I'm 81 years old and won't quit unless you do. Cheers Jim
Q: CRH took a bit of hit today--any particular reason why?
Q: Last week, Resverlogix received a positive confirmation from the FDA that it would likely support approval of BETon MACE based on the result of its Phase 3 study. The stock moved up ~28% today. It shows great promise in treating types of cardiovascular disease. From your experience, is it normal for the FDA to offer a positive comment? Would you have an opinion based on the FDA comment to open a position? I am a prudent investor yet have room for higher risk opportunities.
Thank you
Thank you
Q: Hello Peter and 5i group,
Is LXG interesting enough to buy...?
Thanks, Ken
Is LXG interesting enough to buy...?
Thanks, Ken
Q: I know you like COV and it has been rocketing up. I am wary about buying in now that it's at an all time high after such tear. Should I step in today?